Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Facial nerve function and hearing after microsurgical removal of sporadic vestibular schwannomas in a population-based cohort.

Taha I, Hyvärinen A, Ranta A, Kämäräinen OP, Huttunen J, Mervaala E, Löppönen H, Rauramaa T, Ronkainen A, Jääskeläinen JE, Immonen A, Danner N.

Acta Neurochir (Wien). 2019 Sep 7. doi: 10.1007/s00701-019-04055-4. [Epub ahead of print]

PMID:
31494730
2.

How much rehabilitation are our patients with stroke receiving?

Thompson S, Ranta A, Porter K, Bondi N.

N Z Med J. 2019 Jul 26;132(1499):49-55.

PMID:
31352474
3.

Bringing stroke clinical guidelines to life.

English C, Bayley M, Hill K, Langhorne P, Molag M, Ranta A, Solomon JM, Turner T, Campbell BC.

Int J Stroke. 2019 Jun;14(4):337-339. doi: 10.1177/1747493019833015. Epub 2019 Feb 26.

PMID:
30806591
4.

A Nationwide, Population-Based Prevalence Study of Genetic Muscle Disorders.

Theadom A, Rodrigues M, Poke G, O'Grady G, Love D, Hammond-Tooke G, Parmar P, Baker R, Feigin V, Jones K, Te Ao B, Ranta A, Roxburgh R; On Behalf of the MDPrev Research Group.

Neuroepidemiology. 2019;52(3-4):128-135. doi: 10.1159/000494115. Epub 2019 Jan 18.

5.

Mobile Technology for Primary Stroke Prevention.

Krishnamurthi R, Hale L, Barker-Collo S, Theadom A, Bhattacharjee R, George A, Arroll B, Ranta A, Waters D, Wilson D, Sandiford P, Gall S, Parmar P, Bennett D, Feigin V.

Stroke. 2018 Nov 21:STROKEAHA118023058. doi: 10.1161/STROKEAHA.118.023058. [Epub ahead of print]

PMID:
30580699
6.

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, Asayesh H, Asgedom SW, Atey TM, Ayele HT, Banach M, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Barregard L, Basu S, Bedi N, Behzadifar M, Béjot Y, Bennett DA, Bensenor IM, Berhe DF, Boneya DJ, Brainin M, Campos-Nonato IR, Caso V, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Christensen H, Criqui MH, Damasceno A, Dandona L, Dandona R, Davletov K, de Courten B, deVeber G, Dokova K, Edessa D, Endres M, Faraon EJA, Farvid MS, Fischer F, Foreman K, Forouzanfar MH, Gall SL, Gebrehiwot TT, Geleijnse JM, Gillum RF, Giroud M, Goulart AC, Gupta R, Gupta R, Hachinski V, Hamadeh RR, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Hegazy MI, Hibstu DT, James SL, Jeemon P, John D, Jonas JB, Jóźwiak J, Kalani R, Kandel A, Kasaeian A, Kengne AP, Khader YS, Khan AR, Khang YH, Khubchandani J, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kolte D, Kopec JA, Kosen S, Kravchenko M, Krishnamurthi R, Kumar GA, Lafranconi A, Lavados PM, Legesse Y, Li Y, Liang X, Lo WD, Lorkowski S, Lotufo PA, Loy CT, Mackay MT, Abd El Razek HM, Mahdavi M, Majeed A, Malekzadeh R, Malta DC, Mamun AA, Mantovani LG, Martins SCO, Mate KK, Mazidi M, Mehata S, Meier T, Melaku YA, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Miazgowski T, Miller TR, Ibrahim NM, Mohammed S, Mokdad AH, Moosazadeh M, Moran AE, Musa KI, Negoi RI, Nguyen M, Nguyen QL, Nguyen TH, Tran TT, Nguyen TT, Anggraini Ningrum DN, Norrving B, Noubiap JJ, O’Donnell MJ, Olagunju AT, Onuma OK, Owolabi MO, Parsaeian M, Patton GC, Piradov M, Pletcher MA, Pourmalek F, Prakash V, Qorbani M, Rahman M, Rahman MA, Rai RK, Ranta A, Rawaf D, Rawaf S, Renzaho AM, Robinson SR, Sahathevan R, Sahebkar A, Salomon JA, Santalucia P, Santos IS, Sartorius B, Schutte AE, Sepanlou SG, Shafieesabet A, Shaikh MA, Shamsizadeh M, Sheth KN, Sisay M, Shin MJ, Shiue I, Silva DAS, Sobngwi E, Soljak M, Sorensen RJD, Sposato LA, Stranges S, Suliankatchi RA, Tabarés-Seisdedos R, Tanne D, Nguyen CT, Thakur JS, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Nguyen LT, Truelsen T, Tsilimparis N, Tyrovolas S, Ukwaja KN, Uthman OA, Varakin Y, Vasankari T, Venketasubramanian N, Vlassov VV, Wang W, Werdecker A, Wolfe CDA, Xu G, Yano Y, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zhou M, Ziaeian B, Zipkin B, Vos T, Naghavi M, Murray CJL, Roth GA.

N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.

7.

Why the new 'living' Australian Stroke Guidelines matter to New Zealand.

Mahawish K, Barber PA, McRae A, Slark J, Ranta AA.

N Z Med J. 2018 Dec 14;131(1487):12-14. No abstract available.

PMID:
30543606
8.

Endovascular clot retrieval for acute ischaemic stroke in New Zealand.

Burnell AL, Ranta A, Wu T, Fink J, McGuinness B, Caldwell J, Collecutt W, Brew S, Barber PA.

N Z Med J. 2018 Oct 26;131(1484):13-18.

PMID:
30359351
9.

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.

Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Flaherty K, Duley L, England TJ, Havard D, Heptinstall S, James M, Kasonde C, Krishnan K, Markus HS, Montgomery AA, Pocock S, Randall M, Ranta A, Robinson TG, Scutt P, Venables GS, Sprigg N.

Health Technol Assess. 2018 Aug;22(48):1-76. doi: 10.3310/hta22480.

10.

Impacts for Children Living with Genetic Muscle Disorders and their Parents - Findings from a Population-Based Study.

Jones KM, O'Grady G, Rodrigues MJ, Ranta A, Roxburgh RH, Love DR, Theadom A; MD-PREV study group.

J Neuromuscul Dis. 2018;5(3):341-352. doi: 10.3233/JND-170287.

PMID:
30040738
11.

Impact of discontinuation of telestroke: the Nelson experience.

Ranta A, Busch S.

N Z Med J. 2018 Jun 22;131(1477):29-34.

PMID:
29927913
12.
13.

Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study.

Jones KM, Bhattacharjee R, Krishnamurthi R, Blanton S, Barker-Collo S, Theadom A, Thrift AG, Wolf SL, Venketasubramanian N, Parmar P, Maujean A, Ranta A, Cadilhac D, Sanya EO, MacKay-Lyons M, Pandian JD, Arora D, Obiako RO, Saposnik G, Balalla S, Bornstein NM, Langhorne P, Norrving B, Brown N, Brainin M, Taylor D, Feigin VL.

Clin Rehabil. 2018 Aug;32(8):1086-1097. doi: 10.1177/0269215518777565. Epub 2018 May 30.

PMID:
29843517
14.

Impact of General Practitioner Transient Ischemic Attack Training on 90-Day Stroke Outcomes: Secondary Analysis of a Cluster Randomized Controlled Trial.

Ranta A, Dovey S, Gommans J, Tilyard M, Weatherall M.

J Stroke Cerebrovasc Dis. 2018 Jul;27(7):2014-2018. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.064. Epub 2018 Mar 30.

PMID:
29610038
15.

Appropriateness of general practitioner imaging requests for transient ischaemic attack patients: secondary analysis of a cluster randomised controlled trial.

Ranta A, Weatherall M, Gommans J, Tilyard M, Odea D, Dovey S.

J Prim Health Care. 2017 Jun;9(2):131-135. doi: 10.1071/HC17005.

PMID:
29530224
16.

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.

Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Duley L, England TJ, Flaherty K, Havard D, Heptinstall S, James M, Krishnan K, Markus HS, Montgomery AA, Pocock SJ, Randall M, Ranta A, Robinson TG, Scutt P, Venables GS, Sprigg N; TARDIS Investigators.

Lancet. 2018 Mar 3;391(10123):850-859. doi: 10.1016/S0140-6736(17)32849-0. Epub 2017 Dec 20.

17.

Intravenous alteplase and endovascular clot retrieval following reversal of dabigatran with idarucizumab.

Tse DM, Young L, Ranta A, Barber PA.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):549-550. doi: 10.1136/jnnp-2017-316449. Epub 2017 Oct 6. No abstract available.

PMID:
28986468
18.

Impact and implementation of a sustainable regional telestroke network.

Ranta A, Lanford J, Busch S, Providence C, Iniesta I, Rosemergy I, Wilson A, Cariga P, Richmond V, Gommans J.

Intern Med J. 2017 Nov;47(11):1270-1275. doi: 10.1111/imj.13557.

PMID:
28742223
19.

Yield of head computed tomography in patients with new onset of transient headaches.

Hammond N, Ranta A.

Intern Med J. 2017 Oct;47(10):1141-1146. doi: 10.1111/imj.13517.

PMID:
28589641
20.

Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome.

Buenz EJ, Parry GJ, Ranta A.

Ther Adv Neurol Disord. 2017 Jan;10(1):76-77. doi: 10.1177/1756285616659978. Epub 2016 Aug 16. No abstract available.

21.

Low lymphatic vessel density associates with chronic rhinosinusitis with nasal polyps.

Luukkainen A, Seppälä M, Renkonen J, Renkonen R, Hagstrő M J, Huhtala H, Rautiainen M, Myller J, Paavonen T, Ranta A, Torkkeli T, Toppila-Salmi S.

Rhinology. 2017 Jun 1;55(2):181-191. doi: 10.4193/Rhin16.007.

PMID:
28434015
22.

Provision of stroke thrombolysis services in New Zealand: changes between 2011 and 2016.

Liu Q, Ranta AA, Abernethy G, Barber PA.

N Z Med J. 2017 Apr 7;130(1453):57-62.

PMID:
28384148
23.

Trends in New Zealand stroke thrombolysis treatment rates.

Liu Q, Ranta AA, Abernethy G, Barber PA.

N Z Med J. 2017 Apr 7;130(1453):50-56.

PMID:
28384147
24.

Guillain-Barré syndrome: surveillance and cost of treatment strategies.

Buenz EJ, Parry GJ, Ranta A.

Lancet. 2017 Jan 21;389(10066):253. doi: 10.1016/S0140-6736(17)30047-8. Epub 2017 Jan 20. No abstract available.

PMID:
28118916
25.

Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.

Bath PM, Appleton JP, Beridze M, Christensen H, Dineen RA, Duley L, England TJ, Heptinstall S, James M, Krishnan K, Markus HS, Pocock S, Ranta A, Robinson TG, Flaherty K, Scutt P, Venables GS, Woodhouse LJ, Sprigg N.

Int J Stroke. 2017 Jul;12(5):524-538. doi: 10.1177/1747493016677988. Epub 2016 Nov 4.

26.

Looking for the "perfect" TIA risk score.

Ranta A.

Neurology. 2016 Aug 30;87(9):856-7. doi: 10.1212/WNL.0000000000003052. Epub 2016 Jul 29. No abstract available.

PMID:
27473133
27.

Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012.

Barber PA, Krishnamurthi R, Parag V, Anderson NE, Ranta A, Kilfoyle D, Wong E, Green G, Arroll B, Bennett DA, Witt E, Rush E, Minsun Suh F, Theadom A, Rathnasabapathy Y, Te Ao B, Parmar P, Feigin VL; ARCOS IV Study Group.

Stroke. 2016 Sep;47(9):2183-8. doi: 10.1161/STROKEAHA.116.014010. Epub 2016 Jul 28.

PMID:
27470991
28.

Cranial polyneuropathy caused by varicella zoster reactivation.

Mitchell J, Baguley K, Balm M, Ranta AA.

N Z Med J. 2016 Jul 15;129(1438):64-5. No abstract available.

PMID:
27447138
29.

Stroke thrombolysis in New Zealand: data from the first 6 months of the New Zealand Thrombolysis Register.

Joshi P, Fink J, Barber PA, Davis A, Lanford J, Seymour A, Wright P, Busby W, Abernethy G, Ranta AA.

N Z Med J. 2016 Jul 15;129(1438):44-9.

PMID:
27447135
30.

The Australian and New Zealand regional neurology training survey.

McAulay-Powell C, Ranta A.

Intern Med J. 2016 Jun;46(6):742-4. doi: 10.1111/imj.13103.

PMID:
27257152
31.

The importance of specialized stroke care for patients with TIA.

Ranta A, Alderazi YJ.

Neurology. 2016 May 31;86(22):2030-1. doi: 10.1212/WNL.0000000000002727. Epub 2016 May 4. No abstract available.

PMID:
27164700
32.

Author Response.

Ranta A, Dovey S.

Neurology. 2015 Nov 3;85(18):1637. No abstract available.

PMID:
26839936
33.

International Telestroke: The First Five Cases.

Ranta A, Whitehead M, Gunawardana C, Cariga P, Iniesta I, Watson I, Reoch A.

J Stroke Cerebrovasc Dis. 2016 Apr;25(4):e44-5. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.028. Epub 2016 Jan 26.

PMID:
26825351
34.

Transient ischemic attack service provision: A review of available service models.

Ranta A, Barber PA.

Neurology. 2016 Mar 8;86(10):947-53. doi: 10.1212/WNL.0000000000002339. Epub 2016 Jan 22. Review.

PMID:
26802089
35.

Radiological findings of a symptomatic carotid pseudocclusion: «Guadiana river sign».

Iniesta I, Lamballe A, Rodríguez M, Duignan J, Zaman S, Watson I, Cariga P, Ranta A.

Neurologia. 2017 Jun;32(5):334-337. doi: 10.1016/j.nrl.2015.09.003. Epub 2015 Nov 3. English, Spanish. No abstract available.

36.

New Zealand's neurologist workforce: a pragmatic analysis of demand, supply and future projections.

Ranta AA, Tiwari P, Mottershead J, Abernethy D, Simpson M, Brickell K, Lynch C, Walker E, Frith R.

N Z Med J. 2015 Aug 7;128(1419):35-44.

PMID:
26365844
37.

Myoclonic occipital photosensitive epilepsy with dystonia (MOPED): A familial epilepsy syndrome.

Sadleir LG, Paterson S, Smith KR, Redshaw N, Ranta A, Kalnins R, Berkovic SF, Bahlo M, Hildebrand MS, Scheffer IE.

Epilepsy Res. 2015 Aug;114:98-105. doi: 10.1016/j.eplepsyres.2015.04.014. Epub 2015 May 5.

PMID:
26088892
38.

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).

TARDIS Trial Investigators, Krishnan K, Beridze M, Christensen H, Dineen R, Duley L, Heptinstall S, James M, Markus HS, Pocock S, Ranta A, Robinson T, Nikola N, Venables G, Bath P.

Int J Stroke. 2015 Oct;10(7):1159-65. doi: 10.1111/ijs.12538. Epub 2015 Jun 16.

39.

Health economics of cerebrovascular disease: Can we do better?

Ranta A, Lichtman JH.

Neurology. 2015 Jun 2;84(22):2204-5. doi: 10.1212/WNL.0000000000001651. Epub 2015 May 1. No abstract available.

PMID:
25934850
40.

Cluster randomized controlled trial of TIA electronic decision support in primary care.

Ranta A, Dovey S, Weatherall M, O'Dea D, Gommans J, Tilyard M.

Neurology. 2015 Apr 14;84(15):1545-51. doi: 10.1212/WNL.0000000000001472. Epub 2015 Mar 20.

PMID:
25795645
41.

Methodology of the Stroke Self-Management Rehabilitation Trial: an international, multisite pilot trial.

Jones KM, Bhattacharjee R, Krishnamurthi R, Blanton S, Theadom A, Barker-Collo S, Thrift A, Parmar P, Maujean A, Ranta A, Sanya E, Feigin VL; SMART Study Group.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):297-303. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.029. Epub 2014 Dec 10.

PMID:
25498738
42.

Utility of a primary care based transient ischaemic attack electronic decision support tool: a prospective sequential comparison.

Ranta A, Yang CF, Funnell M, Cariga P, Murphy-Rahal C, Cogger N.

BMC Fam Pract. 2014 May 6;15:86. doi: 10.1186/1471-2296-15-86.

43.

Emergency and stroke physician combined consensus statement on thrombolysis for acute stroke.

Ranta A, Bonning J, Fink J, Fleischer D, Gommans J, Jones P, Barber PA, Ardagh M.

N Z Med J. 2014 Apr 11;127(1392):113-4. Review.

PMID:
24806258
45.
46.

Transient ischameic attack/stroke electronic decision support: a 14-month safety audit.

Lavin TL, Ranta A.

J Stroke Cerebrovasc Dis. 2014 Feb;23(2):267-70. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.022. Epub 2013 Apr 11.

PMID:
23583423
47.

Reflux symptoms and side effects among patients with gastroesophageal reflux disease at baseline, during treatment with PPIs, and after Nissen fundoplication.

Rantanen T, Kiljander T, Salminen P, Ranta A, Oksala N, Kellokumpu I.

World J Surg. 2013 Jun;37(6):1291-6. doi: 10.1007/s00268-013-1979-8.

PMID:
23463398
48.

Changes in the provision of transient ischaemic attack services in New Zealand 2008 to 2013.

Brownlee W, Ranta A, Dale-Gandar J, Bennett P, Gommans J, Fink J, Barber PA.

N Z Med J. 2014 Mar 7;127(1390):23-9.

PMID:
24670586
49.

Efficacy and safety of a TIA/stroke electronic support tool (FASTEST) trial: study protocol.

Ranta A, Dovey S, Weatherall M, O'Dea D.

Implement Sci. 2012 Oct 31;7:107. doi: 10.1186/1748-5908-7-107.

50.

Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.

Kiljander T, Rantanen T, Kellokumpu I, Kööbi T, Lammi L, Nieminen M, Poussa T, Ranta A, Saarelainen S, Salminen P.

Clin Respir J. 2013 Jul;7(3):281-7. doi: 10.1111/crj.12005. Epub 2012 Oct 24.

PMID:
23006321

Supplemental Content

Support Center